Biotech · Private company · St Louis, MO, US
Antiger Therapeutics Inc.
Track this companyFree. Adds Antiger Therapeutics Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Peptide-HLA-DQ8 biologics for antigen-specific therapy in Type 1 DiabetesFiscal year 2025 · $303.3KNIH RePORTER 1R43AI183983-01A1 · fetched Nov 12, 2026
- Peptide-HLA-DQ2 biologics for antigen-specific therapy in Celiac DiseaseFiscal year 2024 · $293.7KNIH RePORTER 1R43AI186651-01 · fetched Nov 12, 2026